GCM
ATRS

Graham Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Graham Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,048
Closed -$196K – 1324
2022
Q1 		$196K Buy
+48,048
New +$174K 0.01% 829

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Graham Capital Management's ATRS Position: Q2 2022 in Review

Graham Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 48,048 shares — an estimated $196K sold.

Graham Capital Management first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $196K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Graham Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Graham Capital Management sold 48,048 Antares Pharma, Inc. shares in Q2 2022, an estimated $196K.
  • Graham Capital Management first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • Graham Capital Management's Antares Pharma, Inc. position peaked at $196K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Graham Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.